SPL 0.00% 9.5¢ starpharma holdings limited

Starpharma's DEP® remdesivir versus Gilead's Veklury (Remdesivir), page-6

  1. 12,924 Posts.
    lightbulb Created with Sketch. 1451
    @stan02

    Can we assume that due to water solubility of
    DEP® remdesivir
    there is no need to incorporate the excipient captisol? This would increase the scope of the medication to the elderly which are more susceptible to severe loss of renal function or acute renal failure.


    That is exactly correct
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.